Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinoma

Cancer Medicine

Volumn 4, Issue 11, 2015, Pages 1700-1704

  Becker, Jessica ^a   May, Andrea ^b   Gerges, Christian ^c   Anders, Mario ^d,e   Veits, Lothar ^f   Weise, Katharina ^a   Czamara, Darina ^g   Lyros, Orestis ^h   Manner, Hendrik ⁱ   Terheggen, Grischa ^c   Venerito, Marino ^j   Noder, Tania ^d   Mayershofer, Rupert ^k   Hofer, Jan Hinnerk ^l   Karch, Hans Werner ^m   Ahlbrand, Constantin J ⁿ   Arras, Michael ⁿ   Hofer, Sebastian ⁿ   Mangold, Elisabeth ^a   Heilmann Heimbach, Stefanie ^a   Heinrichs, Sophie K M ^a   Hess, Timo ^a   Kiesslich, Ralf ⁱ   Izbicki, Jakob R ^d   Hölscher, Arnulf H ^o   Bollschweiler, Elfriede ^o   Malfertheiner, Peter ^j   Lang, Hauke ⁿ   Moehler, Markus ⁿ   Lorenz, Dietmar ^b   Müller Myhsok, Bertram ^g   Ott, Katja ^p,q   Schmidt, Thomas ^q   Whiteman, David C ^r   Vaughan, Thomas L ^s,t   Nöthen, Markus M ^a   Hackelsberger, Andreas ^u   Schumacher, Brigitte ^c,v   Pech, Oliver ^w   Vashist, Yogesh ^d   Vieth, Michael ^f   Weismüller, Josef ^x   Neuhaus, Horst ^c   Rösch, Thomas ^d   Ell, Christian ^b   Gockel, Ines ^h,n   Schumacher, Johannes ^a   more..

^a UNIVERSITY OF BONN   (Germany)

^b SANA KLINIKUM OFFENBACH   (Germany)

^c Children s Hospital   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e Vivantes Wenckebach Kinikum ^*  (Germany)

^f INSTITUTE OF PATHOLOGY   (Germany)

^g MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^h UNIVERSITY HOSPITAL LEIPZIG   (Germany)

ⁱ HSK Hospital   (Germany)

^j OTTO VON GUERICKE UNIVERSITY   (Germany)

^k Gastroenterologie am Burgweiher   (Germany)

^l Magen Darm Zentrum   (Germany)

^m Gastroenterologische Schwerpunktpraxis   (Germany)

ⁿ JOHANNES GUTENBERG UNIVERSITY   (Germany)

^o UNIVERSITY OF COLOGNE   (Germany)

^p UNIVERSITY OF HEIDELBERG   (Germany)

^q Klinikum Rosenheim   (Germany)

^r QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^s UNIVERSITY OF WASHINGTON   (United States)

^t USA   (United States)

^u Gastropraxis   (Germany)

^v ELISABETH KRANKENHAUS ESSEN   (Germany)

^w Oncology and Hematology   (Germany)

^x Gastroenterologische Gemeinschaftspraxis   (Germany)

more..

Author keywords

FOXF1; FOXP1; BARX1; Esophageal adenocarcinoma; Genetic association study

Indexed keywords

TRANSCRIPTION FACTOR GATA 6; BARX1 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXF1 PROTEIN, HUMAN; FOXP1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BARRETT ESOPHAGUS; BARX1 GENE; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; FOXF1 GENE; FOXP1 GENE; GATA6 GENE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; XRCC2 GENE; ADENOCARCINOMA; ADOLESCENT; ADULT; ALLELE; CASE CONTROL STUDY; ESOPHAGEAL NEOPLASMS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; ODDS RATIO; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 85006219586     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.500     Document Type: Article

References (11)

1. Levine, D. M., W. E. Ek, R. Zhang, X. Liu, L. Onstad, C. Sather, et al. 2013. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat. Genet. 45:1487-1493.
2. Gu, Y., S. Lin, J. L. Li, H. Nakagawa, Z. Chen, B. Jin, et al. 2012. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. Oncogene 31:469-479.
3. Woo, J., I. Miletich, B. M. Kim, P. T. Sharpe, and R. A. Shivdasani . 2011. Barx1-mediated inhibition of Wnt signaling in the mouse thoracic foregut controls tracheo-esophageal septation and epithelial differentiation. PLoS ONE 6:e22493.
4. Koon, H. B., G. C. Ippolito, A. H. Banham, and P. W. Tucker . 2007. FOXP1: a potential therapeutic target in cancer. Expert Opin Ther. Targets 11:955-965.
5. Shu, W., M. M. Lu, Y. Zhang, P. W. Tucker, D. Zhou, and E. E. Morrisey . 2007. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development 134:1991-2000.
6. Su, Z., L. J. Gay, A. Strange, C. Palles, G. Band, D. C. Whiteman, et al. 2012. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat. Genet. 44:1131-1136.
7. Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. Ferreira, D. Bender, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559-575.
8. Thacker, J. 2005. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 219:125-135.
9. Alvarez, H., J. Opalinska, L. Zhou, D. Sohal, M. J. Fazzari, Y. Yu, et al. 2011. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 7:e1001356.
10. Kimchi, E. T., M. C. Posner, J. O. Park, T. E. Darga, M. Kocherginsky, T. Karrison, et al. 2005. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 65:3146-3154.
11. Lin, L., A. J. Bass, W. W. Lockwood, Z. Wang, A. L. Silvers, D. G. Thomas, et al. 2012. Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proc. Natl. Acad. Sci. USA 109:4251-4256.